Improving healthcare consumer effectiveness: An Animated, Self-serve, Web-based Research Tool (ANSWER) for people with early rheumatoid arthritis

BACKGROUND: People with rheumatoid arthritis (RA) should use DMARDs (disease-modifying anti-rheumatic drugs) within the first three months of symptoms in order to prevent irreversible joint damage. However, recent studies report the delay in DMARD use ranges from 6.5 months to 11.5 months in Canada....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linda C, Adam, Paul, Townsend, Anne F, Stacey, Dawn, Lacaille, Diane, Cox, Susan, McGowan, Jessie, Tugwell, Peter, Sinclair, Gerri, Ho, Kendall, Backman, Catherine L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733893/
https://www.ncbi.nlm.nih.gov/pubmed/19695086
http://dx.doi.org/10.1186/1472-6947-9-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733893/
https://www.ncbi.nlm.nih.gov/pubmed/19695086
http://dx.doi.org/10.1186/1472-6947-9-40

Ejemplares similares